Imvax appoints Wendy DiCicco to board
Ms. DiCicco is a veteran healthcare executive with financial, operational and corporate development experience.
Ms. DiCicco is a leader in the emerging growth life sciences community, and has served in the roles of board member, financial and operational executive, and advisory consultant.
She also serves on the boards of EyePoint Pharmaceuticals, where she is the audit committee chair, Carmell Therapeutics, and ExpressCells, life sciences companies in the respective fields of ophthalmic pharmaceuticals, plasma-based regenerative medicine, and gene editing.
Ms. DiCicco received a B.S. in accounting from Philadelphia College of Textiles and Science and is a licensed CPA. ■